Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

The Biggest Customs Clearance Hurdles Facing The Life Sciences Industry: How to Manage Heightened Bribery Risks when Dealing with Customs Officials, Agents and Brokers

Events

April 27, 2015

Bass, Berry & Sims attorney John Kelly will speak on April 27 at American Conference Institute's (ACI) 9th Advanced Conference on FCPA & Anti-Corruption for the Life Sciences Industry. John's session is titled "The Biggest Customs Clearance Hurdles Facing The Life Sciences Industry: How to Manage Heightened Bribery Risks when Dealing with Customs Officials, Agents and Brokers."

During this session, the speakers will impart best practices for minimizing exposure in high risk markets. In addition, they will highlight risks that are unique to each of these important markets and explain how best to tailor your compliance strategies to each jurisdictional context.

The conference will be held April 27-28 in New York, New York. For more information and registration, visit the ACI website.


In Case You Missed It:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.